We are delighted to append the link/copy of this knowledge expanding and practice changing publication in The Lancet. We are a proud member of the ORFAN consortium and the writing committee. This work with the contribution of our local research group (TCRG-MKUH) Translational Cardiovascular Research Group – Milton Keynes University Hospital is a milestone of its kind. … Read more
Continuous technologic development and updated recommendations for image acquisitions creates aneed to update the current normal reference ranges for echocardiography. The best method of indexing cardiac volumes is unknown. Click here to read the full article on the subject.
Here is an interesting insight from the ASIAN-HF Registry on Heart failure and left ventricular ejection fraction in the normal range (HFnEF) being understudied. Click here to read the full article.
Device-detected atrial high-rate episodes (AHREs) are atrial arrhythmias detected by implanted cardiac devices. AHREs resemble atrial fibrillation but are rare and brief. Whether the occurrence of AHREs in patients without atrial fibrillation (as documented on a conventional electrocardiogram [ECG]) justifies the initiation of anticoagulants is not known. Please take a look at the full article … Read more
There is a new release showing the reduced value of CT-FFR in chest pain assessment published as a pre release in JACC-Cardiovascular Imaging. The article can be found here.
There is an excellent video available on the NEJM. The video summarises new research findings on whether percutaneous coronary intervention when added to optimal medical therapy can improve outcomes in patients with severe ischemic left ventricular systolic dysfunction is unknown. Please click here to visit.
There is an excellent article on this topic to be found on the New England Journal of Medicine. Please click here to read it in full.
The New England Medical Journal have published an excellent article on this topic. It explores the effectiveness of CT and ICA when trying to manage the frequency of major adverse cardiovascular events. To read the full article, click here to go to the New England Medical Journal.